OdyssION Platform
Native mass spectrometry drug discovery platform for membrane and complex-bound targets
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
OdyssION is OMass Therapeutics' proprietary drug discovery platform. It uses biochemistry that preserves a target's native partners and lipids, patent-protected native mass spectrometry to measure the physical interactions that drive biology, and MS-enabled custom chemistry, aiming to give cell-system fidelity with cell-free precision on hard targets such as solute carriers, GPCRs and the inflammasome.
- Website
- omass.com/science
- Added via
- web
- Ownership
- unclaimed
Where to go
Product details
- Product kind
- Other